Jordan: Jordan's Ram Pharmaceutical Industries and Saudi Arabia's Cigalah Healthcare have launched an investment partnership aimed at strengthening value-added investment in Jordan and expanding Jordanian-Saudi economic cooperation.
According to Jordan News Agency, the launch ceremony was attended by Minister of Investment Tareq Abu Ghazaleh, who highlighted the deep-rooted ties between Jordan and Saudi Arabia, emphasizing that this partnership reflects the depth of economic relations and confidence among private-sector institutions. The collaboration signifies a pivotal step towards enhanced Arab economic integration, particularly in the strategic pharmaceutical sector.
Minister Abu Ghazaleh noted that investing in pharmaceuticals and healthcare is an investment in people and quality of life. He stressed that a robust pharmaceutical industry is critical for health security and national economic resilience. Jordan, with its advanced pharmaceutical manufacturing sector, exports products to numerous regional and global markets, showcasing its capability in this strategic field.
Under the Economic Modernization Vision, the Jordanian government prioritizes value-added industries like pharmaceuticals for sustainable growth and quality job creation. Abu Ghazaleh asserted that this partnership reflects confidence in Jordan's favorable investment environment, which includes modern legislation, competitive advantages, a skilled workforce, advanced infrastructure, and access to regional and global markets.
He extended his congratulations to Ram Pharmaceutical Industries and Cigalah Healthcare for their strategic partnership, expressing hope that it would serve as a model for future Arab investment partnerships and regional economic integration. Participants in the launch event echoed these sentiments, noting that the partnership would bolster economic cooperation between Jordan and Saudi Arabia and could pave the way for new prospects in Arab economic integration.
The partnership comes at a time of increasing regional and international interest in the pharmaceutical industry, seen as a strategic sector supporting health security, supply chains, technology transfer, exports, and job creation. It leverages the strengths of two leading companies in the pharmaceutical and healthcare sectors, both with significant presence in Arab and international markets.